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Abstract  
Management guidelines for Type 1 diabetes (T1DM) aim to improve outcomes by reducing 
the development of long term complications of diabetes.  Management targets focus 
primarily on glycaemic control, but include other factors, such as control of blood lipids and 
maintenance of psychosocial well-being.  Efforts to achieve diabetes targets should focus 
on patient centred care, making diabetes self-management education an important part of 
diabetes management. The introduction of the 5-day Dose Adjustment for Normal Eating 
(DAFNE) program in 2005 enabled Australians to access evidence-based structured 
education in intensive diabetes self-management, or flexible multiple daily injection (MDI) 
therapy, allowing greater dietary and lifestyle freedom.  The introduction of this program 
raised some concerns among clinicians, namely, the potential for negative impact on 
dietary quality and the difficulty with access to a long duration program for some patients.  
In addition, there were concerns that the numeracy demands of flexible dose calculation 
may be beyond the capability of some patients. 
 
Aims of the thesis were to: 
• Examine the impact of a well established structured patient-based flexible MDI education 
program (The Dose Adjustment for Normal Eating program) which promotes increased 
dietary freedom, on dietary intake of energy and macronutrients and achievement of 
nutritional recommendations. 
• Describe patient perspectives on the useability of a novel iphone application, designed to 
support flexible MDI therapy, with the aim of informing further development of this self-
management tool 
• Develop and pilot an abbreviated short-course format for structured flexible multiple 
injection therapy  and evaluate patient experience and psychosocial outcomes. 
 
Chapter 2 describes the impact on dietary intake following flexible MDI education that 
actively promotes dietary freedom.  We were able to demonstrate that achievement of 
nutritional recommendations does not worsen when adults with T1DM are taught how to 
manage flexible insulin dosing with dietary freedom.  We noted that individuals found it 
possible to reduce energy and carbohydrate intake, without increasing hypoglycaemia, 
which may offer benefits to weight control efforts. 
Chapter 3 addresses patient perspectives of a novel iphone application designed to assist 
with dose calculation, record keeping and communication with health professionals for 
adults using flexible MDI therapy. We identified specific features of an iphone app that 
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users deemed useful to support patient-based management and this will go to inform 
further app development. 
Chapter 4 describes patient experience and psychosocial outcomes of a structured flexible 
MDI education program, delivered in short-duration format .  We found the short course 
education program was well tolerated by participants and improvements in psychosocial 
outcomes for this short program were consistent with that seen with the 5-day program.   
 
In conclusion, this work adds to the knowledge base about the flexible MDI self-
management education in terms of dietary implications, patient perspectives on phone-
based devices to support self-management and preliminary exploration of alternative 
program delivery options for patient education.  Further evaluation of the short-course 
program, specifically focusing on glycaemic outcomes, may shed light on alternative 
course options for those who are unable to attend a 5-day program. 
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Chapter 1  Introduction 
Type 1 diabetes (T1DM) management is driven by the focus on achievement of glycaemic 
targets to minimise the risk of long term diabetes complications.  The landmark 
DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes 
Interventions and Complications) study conducted in the 1980s demonstrated that 
achievement of glycaemia as close to possible to the non-diabetic range reduces the risk 
of  micro-vascular and macro-vascular complications of diabetes.  DCCT intensive 
diabetes management, included standardised procedures across study centres, such as 
frequency of SMBG (≥4/day), frequency and type of insulin (≥3/day regular insulin and 
intermediate insulin or insulin pump therapy), use of specific glycaemic targets (pre meals, 
post meals and at 3 am) and intensive clinic follow up (monthly clinic visits and more 
frequent telephone contact).  Compared to conventional treatment at the time, which 
involved limited urine or blood glucose monitoring (once/day), reduced frequency of 
injections (1-2/day), no specific glucose targets and quarterly clinic visits, intensive 
treatment significantly improved median glycosylated haemoglobin (HbA1c) (9.4% vs 
7.2%).   However, this improvement came at the cost of a 3-fold increase risk of severe 
hypoglycaemia and a 33% increased risk of becoming overweight.  There was no impact 
on quality of life according to treatment modality. Following the DCCT, intensive therapy 
was offered at all centres and participants returned to care in their usual centre.  The 
difference in HbA1c between former treatment groups reduced at 1 year and by the 5th 
year after the end of the formal trial, there was no difference between former treatment 
groups (8.1 vs 8.2%)1.   
 
The DCCT intensive treatment regimen was largely physician-led and a structured 
education curriculum was not used, resulting in varied approaches to patient education 
and management strategies.  Dietary education for example, included 4 different options 
for meal planning and carbohydrate management education, from healthy food choices (no 
carbohydrate quantification) to total available glucose (where carbohydrate, fat and protein 
units are counted in the determination of insulin doses)2. When participants returned to 
usual centres, some centres were not involved in the DCCT and may not have had the 
expertise to optimally manage intensive therapy 1.  The rebound in HbA1c to 8% may be a 
result of this ‘dilution’ of specialised diabetes support or the reduction in support upon the 
return to quarterly clinic visits in patients who were accustomed to a physician-led 
approach to diabetes management. 
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In Germany around the same time, the Diabetes Teaching and Training Program (DTTP)  
was developed, which utilised an alternative approach to intensive diabetes management3.  
In contrast to the DCCT, the DTTP was delivered with a 5-day education program, with no 
extra follow up apart from usual care.  The DTTP used a structured education curriculum, 
which ensured consistent diabetes management strategies across all centres.  There was 
an active promotion of dietary and lifestyle flexibility and a patient-based approach to 
intensive diabetes management.  The initial evaluation of the DTTP in 78 unselected 
adults with T1DM demonstrated a significant reduction in HbA1c (expressed as amount 
percent of total haemoglobin above the upper limit of normal range) from +2.6 (2) to +1.0 
(1.7)3.  This program has subsequently been taken up by other countries and is now the 
standard of care in Germany where it is linked with a national continuous quality–
assurance program4.  Samaan and colleagues reported on the audit data from this 
national program, which included 9583 patients for the period of 1992 – 2004.4    Twelve 
months post course, mean SD HbA1c improved (8.1 2 to 7.3 1.5%), severe 
hypoglycaemia reduced (0.37 to 0.14 episodes/patient/year) compared to baseline and 
there was no weight gain. The DTTP program has since served as the basis for the Dose 
Adjustment for Normal Eating (DAFNE) in the UK (UKDAFNE) and Australia (OzDAFNE).  
Both programs use the DTTP program curriculum adapted for local conditions together 
with an active promotion the ‘freedom to eat’ approach. The Australian experience with 
DAFNE began in 2004 when five Australian centres were trained in the UK and courses 
began in 20055. The first OzDAFNE audit, which reviewed data from Australian centres 
from 2005 to 2007 demonstrated an improvement in mean (sd) HbA1c at baseline of 8.2% 
(1.2) to 7.8% (1.3) 12 months post course, with the greatest HbA1c reduction seen in 
those with higher baseline HbA1c,5  which was also seen in a subsequent audit of the 
OzDAFNE (from 2007 to 2012). 
 
Twelve month outcome data for structured flexible MDI education delivered as DTTP, 
UKDAFNE and OzDAFNE demonstrate similar trends in HbA1c, severe hypoglycaemia,  
weight, improvement in quality of life, treatment satisfaction and reduction in diabetes 
distress.5-8  Longer term follow up of this ‘one off’ exposure to structured education has 
demonstrated ongoing significant improvements in HbA1c beyond 12 months post course, 
though with some rebound in HbA1c resulting in overall mean HbA1c reduction form 
baseline of approximately 0.3-0.5% HbA1c at 4 years 9,10 and 7 years.11  in contrast, the 
reduction in frequency of severe hypoglycaemia, is well maintained with no rebound from 
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12 months to 6 years 12 and 12 years13.  Similarly, improvement in quality of life also is 
also well maintained with no rebound, up to 44 month post intervention.10 
 
In Australia, initial local support for the program was mixed, with some concerns about 
promoting dietary freedom and the potential negative impact that this would have on 
nutritional intake.  Diabetes associations have published nutritional recommendations 14,15 
to address the risk factors for cardiovascular disease.  These recommendations are 
consistent across countries, addressing macronutrient, saturated fat, fibre and alcohol 
intake, however poor achievement of these guidelines are commonplace, in those with 
T1DM as well as the general population16-19. Historically, dietary prescription of 
macronutrients has been the mainstay of dietary management of diabetes, with a focus on 
controlling carbohydrate ‘portion’ intake to enable the ‘matching’ of dietary carbohydrate to 
insulin doses, and prescription of remaining dietary components to achieve recommended 
macronutrient intake20.  There were concerns that focusing on carbohydrate counting and 
introducing an active promotion of dietary freedom could potentially ‘worsen’ nutrient 
intake.  Previous assessment of dietary intake has been conducted in the setting of flexible 
MDI education21,22 however quantitative assessment of energy and macronutrient intake in 
this setting where there is an active promotion of dietary freedom had not yet been 
performed.  We felt that the concerns about potential dietary quality were valid, therefore 
we set out to conduct the first quantitative assessment of energy and nutrient intake 
following the introduction of the DAFNE program in Australia23.  Chapter 2 describes the 
nutritional intake of DAFNE participants in one centre over a two year period and 
specifically addresses 1) comparison of nutritional intake to recommendations and 2) 
impact of course participation on dietary intake of energy and macronutrients.  
 
The duration of the 5-day DAFNE program has also raised some concerns relating to 
access to the program by both patients and health professionals.  Many patients struggled 
to attend a program conducted over 5 consecutive days (40 hours) and some diabetes 
centres which were keen to deliver the program, were not able to commit personnel for 5 
days. To address this issue, shorter duration programs have been developed, with some 
reporting significant improvements in glycaemic control24,25. Intensive flexible MDI 
education programs in ‘short-course’ format differ in course design and delivery; however 
share common themes in course content.  Oswald and colleagues 25 reported significantly 
improved mean SD HbA1c (9.3 1.5 to 8.3 1.4% in sixty four adults with T1DM after 
participation in the Intensified Conventional Therapy (ICT) education program. This 
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program is based on carbohydrate counting and flexible insulin dose algorithms and is 
conducted in group sessions and individual consultations, with an average health 
professional contact time of 90 minutes per patient.  Bendik and colleagues24 reported 
reduced frequency of severe hypoglycaemia, improved quality of life and increased 
autonomy after the Flexible Insulin Therapy (FIT) education program, which is conducted 
in 90 minute sessions, delivered weekly, for seven weeks.  Both of these programs include 
education on carbohydrate counting, use of insulin dose algorithms and pattern based 
evaluation, which Grant and colleagues26 identified as ‘core’ curriculum components of 
structured flexible MDI self-management education, however a structured curriculum was 
not used. 
 
There has been increased recognition of the importance of delivering patient-based 
flexible MDI education using a structured curriculum27,28.  Structured education programs 
are defined by the following criteria as outlined by Dineen29 and summarised in Figure 1.  
 
Figure 1: Key Criteria of a structured education program29 
• A clear underlying philosophy on which the programme is based 
• A structured written curriculum 
• Trained educator familiar with the programme and its delivery 
• A quality assurance system applied to the structure 
• A process of audit of programme outcomes including biomedical, psychosocial, and 
patient experience 
 
 
The use of the structured curriculum ensures that the education is evidence based, theory 
driven, delivered by experienced instructors and the delivered content is consistent and of 
high quality. Chapter 4 describes the development and outcomes following a short-
duration structured patient-based flexible MDI education program based on OzDAFNE 
principles. 
 
Promotion of insulin self-management requires the patient to manage a variety of 
mathematical calculations, including measuring and weighing foods, multiplying and 
dividing, using decimals, recognising and using fractions and working with ratios and 
percentages30.  Higher level numeracy skills are essential in day to day management of 
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flexible MDI and are related to achievement of glycaemic targets.  Marden and colleagues 
assessed numeracy in 112 adults aged 18 – 65 years with T1DM attending a the 
Bournemouth Diabetes and Endocrine Centre and found that higher numeracy scores 
(those who scored above level  2 - equivalent to 14 – 16 years in the National Curriculum 
Framework in the UK) had significantly lower HbA1c than those scoring below level 2.31 
Common numeracy problems were working with decimals, fractions, using percentages 
and converting units of measure – all skills which are essential to flexible MDI self-
management30.  They identified that 47% of adults had numeracy scores below level 2, 
which is concerning in the setting of insulin self-management education, where numeracy 
skills up to, and at level 2 are considered essential. 31  
 
In addition to influencing long term glycaemic control, poor numeracy may also carry a 
significant risk of short term adverse events.  Sussman and colleagues32 assessed the 
accuracy of ‘on paper’ dose calculations for two glucose scenarios (low glucose and high 
glucose) in 205 adults with diabetes requiring insulin.  They found that 63% of the 
calculations were incorrect. Even more concerning was the range of error seen, which was 
from -12 to +135 Units/dose.   Not surprisingly, this degree of dose miscalculation 
represents a significant risk of hypoglycaemia.  Hypoglycaemia associated with insulin 
administration error is one of the major contributors to emergency department admissions 
due to medication misuse33.   
 
To support safe and appropriate dose calculation, dose calculation tools have been 
developed, initially using a plastic dosing guide34.   Once the efficacy of bolus calculation 
was confirmed with such dosing guides, bolus calculator functionality was included in 
insulin pumps and then subsequently in bolus calculators for those using MDI32,35,36.  Bolus 
calculator functionality has also been incorporated into mobile phone applications.   Given 
the  present ubiquitous nature of mobile “smart” phones, access to bolus calculator 
functionality has significantly increased.  In addition to dose calculation, mobile phone 
apps are also well suited to perform additional necessary functions to support flexible MDI 
management, namely diabetes diary recording and enabling data communication with 
health professionals.  In chapter 3 we describe the qualitative assessment of user 
perspectives of the novel “Rapidcalc” mobile phone application that assists with bolus 
dose calculation, diary recording and communication with health professionals. This user 
perspective provides valuable insights into further development of mobile phone apps 
used to support patient-based flexible MDI. 
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Research questions and aims in this thesis 
The purpose of these studies was to quantitatively assess the impact of a flexible MDI with 
an active promotion of dietary freedom on nutritional intake and to describe innovations 
aimed at improving access to safe and effective flexible MDI therapy. 
 
Research Questions and aims of Chapter 2 
Questions: 
o What is the impact of flexible MDI therapy on energy and nutrient intake? 
o What is the impact of flexible MDI therapy on the achievement of nutrition 
recommendations 
Aims: 
o To conduct a quantitative assessment of energy, macronutrient and fatty acid 
intake in adults with T1DM participating in the DAFNE program 
o To examine the impact on achievement of nutritional recommendations in adults 
with T1DM following DAFNE education 
 
Research Questions and aims of Chapter 3 
Questions: 
o What is the useability of a novel iphone application designed to support intensive 
flexible MDI self-management 
o What existing and additional features users feel are important in a phone app to 
support self-management of flexible MDI therapy 
Aims: 
o To identify patient perspectives on the useability of a novel iphone application  
o To identify additional features to improve useability and support patient-based 
management. 
 
Research Questions and aims of Chapter 4 
Question: 
o What is patient experience following participation in a novel structured short-
course intensive flexible MDI education program and how does this impact 
psychosocial outcomes? 
o How do these psychosocial outcomes compare to the 5-day program? 
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Aims: 
o To describe patient experience and evaluate the impact of a novel short-course 
structured intensive flexible MDI education program on treatment satisfaction, 
diabetes distress and wellbeing. 
o To compare psychosocial outcomes to that seen with the 5-day DAFNE program. 
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Chapter 2: Quantitative assessment of dietary intake in adults 
with Type 1 diabetes following flexible insulin therapy 
education with an active promotion of dietary freedom. 
 
Knight BA, Hickman IJ, Gibbons K, McIntyre HD. 
Diabetes Research and Clinical Practice. 2016;116:36-42. 
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Abstract  
Clinical practice guidelines for diabetes include dietary guidelines to address the increased 
risk of cardiovascular disease.   
Aims: To identify impact of flexible insulin education with an active promotion of dietary 
freedom on energy and macronutrient intake and achievement of nutrient 
recommendations in adults with Type 1 diabetes. 
Methods: Dietary assessment was performed prior to and 12 months following flexible 
insulin education.  Nutrient intake and the proportion achieving the European Association 
for the Study of Diabetes (EASD) nutrient guidelines was compared at baseline and post 
course. 
Results:  Dietary data was available for 46 participants.  Post course reductions were seen 
in median [ IQR ] energy kcal/d (1799 [1521 - 1931] to 1592 [1378 - 1940], p = 0.002), fibre 
g/1000kcal (14 [12-16] to 13 ([11-15], p= 0.047),  protein g/day (89 ([78-108] to 82 [74-93], 
p = 0.001) and carbohydrate g/day (198 [172-330] to 162 [143-204], p = <0.001).  The 
proportion experiencing at least 1 severe hypoglycaemia event over 12 months was 
significantly reduced (χ2 = 7.7, p = 0.006) from baseline (n = 13, 26%) to post course (n = 
3, 6%). Achievement of EASD guidelines was poor and  did not change post course. 
Conclusions:  Flexible insulin education with an active promotion of dietary freedom does 
not appear to ‘worsen’ the achievement of EASD nutrition guidelines in adults with Type 1 
diabetes.  On the contrary, the dietary changes observed were reductions in energy, 
carbohydrate and protein intake. Flexible insulin education may offer benefits in enabling 
reduced energy intake without increasing hypoglycaemia. 
 
 
Keywords: diabetes, flexible insulin, cardiovascular disease, nutrition, diet
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Introduction 
Despite improvements in diabetes care, cardiovascular disease remains the leading cause 
of death in type 1 diabetes mellitus (T1DM)1.   Nutrient recommendations aim to address 
cardiovascular disease risk reduction, with restriction of dietary fat, saturated fat, trans fats 
and cholesterol and increased fibre intake.  Dietary recommendations from the Diabetes 
Nutrition Group of the European Association for the Study of Diabetes and the World 
Health Organisation are summarised in Table 1 2,3.  Despite widespread acceptance of 
dietary  recommendations aimed at reducing cardiovascular risk, low adherence to such 
guidelines has been a common observation in T1DM as well as the general population,  
across a number of countries 4-7.     
 
Historically, dietary prescription of macronutrients has been the mainstay of dietary 
management of diabetes, with a focus on controlling carbohydrate ‘portion’ intake to 
enable the ‘matching’ of dietary carbohydrate according to insulin doses, and prescription 
of remaining dietary components to achieve the recommended macronutrient profile8.  
Since the DCCT 9, greater focus has been given to flexible approaches to insulin dosing, 
which enables a more flexible approach to carbohydrate intake, enabling a greater 
freedom in dietary intake in carbohydrate containing foods. This may direct focus solely to 
carbohydrate and away from a diet that conforms with dietary guidelines 2,8,10,11.  
 
The Dose Adjustment for Normal Eating (DAFNE) program is a flexible insulin therapy 
program, which actively promoted a ‘freedom to eat’ concept, with the motto, ‘Eat what you 
like, like what you eat’ when initially introduced to the United Kingdom and Australia.  
Education relating to healthy eating was included in the OzDAFNE structured curriculum, 
however the focus of the program was the acquisition of patient-based skills in insulin 
adjustment.  Healthy eating was addressed only briefly  and dietary prescription of 
macronutrient intake was not addressed.  This overt promotion of dietary freedom is not 
associated with a detrimental impact on weight and blood lipids 10,12-14, however the impact 
on macronutrient and energy intake has yet to be determined.   
 
The impact of flexible insulin education and ‘modified’ dietary freedom has been previously 
assessed by Chantelau and colleagues15, who conducted a quantitative assessment of 
dietary intake in 48 adults with T1DM participating in the Diabetes Teaching and 
Treatment program (DTTP) where a ‘simplified carbohydrate prescriptive’ approach was 
used, allowing dietary freedom for protein, fat and energy, however carbohydrate intake 
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was prescribed.  Following course participation, carbohydrate, fat, and protein were 
unchanged, as were blood lipids and body weight, though energy intake reduced 
significantly.   
 
More recently, the effect of the DAFNE ‘freedom to eat’ approach has been examined in a 
qualitative study of eating patterns and food choices by Lawton and colleagues16, who 
found food and eating patterns were relatively unchanged following DAFNE course 
participation.  The reasons identified for the relative stability in food choices were dietary 
habituation, lack of interest in introducing new foods and the reluctance to engage in the 
extra effort involved in the determination of the carbohydrate count for ‘new’ foods. 
 
In the management of T1DM, it is common practice for sucrose intake not to be prescribed 
and considered permissible providing the insulin dose caters for it 17,18.  High sucrose 
foods are often also high in fat, saturated fat and energy, therefore increased dietary 
freedom in carbohydrate intake could also potentially raise fat, saturated fat and energy 
intake, thereby further reducing adherence to dietary guidelines.    
The aim of this study is to observe and quantify the impact of flexible insulin therapy 
education with an overt promotion of increased dietary freedom, on energy, macronutrient 
and fat intake in adults with T1DM and achievement of EASD nutrient recommendations. 
 
Material and Methods 
Participants agreed to the use of their non-identifiable data for audit purposes; however no 
formal consent form was used.  The data collection procedures were reviewed by the 
Mater Health Services Human Research Ethics Committee and The University of 
Queensland Medical Research Ethics Committee and the study was exempted as a quality 
assurance activity, consistent with National Health and Medical Research Council 
guidelines19. 
 
Dietary assessment was performed alongside standard data collection procedures in all 
participants attending the DAFNE program at the Queensland Diabetes Centre, Mater 
Health Services, Brisbane, Australia for the first two years of course delivery.   Eligibility 
criteria for DAFNE participation has previously been described 13. The following exclusion 
criteria were applied to the dietary data: pregnancy or clinically diagnosed eating disorder, 
either pre-existing or occurring within 12 months of course participation. 
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In addition to standard audit procedures for biomedical and patient reported data  13, 
dietary data was collected by a specialist diabetes dietitian using an open ended, interview 
administered diet history (DH)20 with a food frequency checklist and analysed using the 
Foodworks Professional program (Xyris Software, version 3.02.581).  Energy kcal/d, 
carbohydrate g/d, fat g/d, saturated fat g/d, cholesterol mg/d and fibre g/1000 kcal/d were 
determined and  Atwater factors were used to determine % contribution to total energy 
intake for protein, fat, carbohydrate, saturated fatty acid, polyunsaturated fatty acid and 
monounsaturated fatty acid 21.  Weight loss intent was determined at baseline and defined 
as ‘desire to lose weight’, ‘desire to gain weight’, ‘no desire to gain or lose weight’.  Severe 
hypoglycaemia data was examined alongside dietary data to identify associations with 
dietary change. 
 
Statistical analysis 
Normally distributed variables were identified using the Shapiro-Wilk test and confirmed by 
examination of normal probability plots.  Data are presented as mean (SD) if normally 
distributed, otherwise as median (interquartile range [IQR]).  For pre and post course 
comparisons, variables were compared using paired t-tests in the event of the change 
variable being normally distributed and Wilcoxon signed rank test otherwise. Change 
variables are described as the mean change (95% CI) if normally distributed, otherwise as 
median change (IQR).  The achievement of each EASD nutritional recommendation was 
compared at baseline and post course using McNemar’s test. Weight loss ‘intent’ was 
identified at baseline and weight loss post course was compared in those intending to lose 
weight versus those not intending to lose weight using the Student’s independent t test. 
Spearman’s Rank correlation coefficient was determined for change in frequency of severe 
hypoglycaemia versus change in energy and nutrient intake.  Categorical analysis was 
performed, using McNemar’s test to compare the proportion of participants experiencing at 
least one event of severe hypoglycaemia pre course versus post course. 
 
Results 
Of the 75 participants eligible for 12 month data collection at the end of the audit period, 
paired pre course and 12 months post course dietary data were available for n = 46 (61%), 
with loss of follow up in n=29.  The baseline characteristics of those who attended at 12 
months post course compared to those who were lost to follow up is shown in table 2.  
There was no difference in age, HbA1c, BMI, frequency of BG monitoring or recording, 
frequency of severe hypoglycaemia or DKA, and dietary intake variables between these 
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two groups.  Those who attended 12 month dietary assessment had longer diabetes 
duration (19.5 [11-26] years vs 9 [7-176], p= 0.002). 
Pre and post course dietary intake is compared in Table 3. Statistically significant 
reductions were seen in energy (kcal/d), carbohydrate (g/d), protein (g/d) and fibre 
(g/1000kcal) intake.  No significant change was detected in other nutrients.  The 
percentage of participants achieving EASD recommendations at baseline and 12 months 
post course is shown in Figure 1.  There was no difference in the proportion achieving 
nutrient recommendations at baseline and 12 months post course (McNemar testing 
shown in figure 1).  Achievement of guidelines was lowest for fibre, saturated fat, protein 
and fat, and  highest for cholesterol, monounsaturated fat and polyunsaturated fat.   
Weight loss intent was available in 44 participants, with 24/44 (55%) intending to lose 
weight at baseline assessment.  At baseline, mean sd BMI was higher in participants 
intending to lose weight (26.5 [3.3] kg/m2), compared to those not intending to lose weight 
(24.0 [2.8] kg/m2; p<0.001).  In participants who intended to lose weight, mean weight loss 
was 0.8 [3.7] kg, compared to a mean [sd] weight gain of 2.1 [5.2] kg, though this failed to 
reach statistical significance (p =0.052).  
The data on severe hypoglycaemia is not shown here as is consistent with what has been  
previously reported 13.  The frequency of severe hypoglycaemia was heavily skewed, with 
approximately 70% of participants failing to experience a severe hypoglycaemic event in 
the 12 months pre-course or during the 12 months follow up period.  Post course, there 
was a significant reduction in the number of severe hypoglycaemic events/12 months 
(p=0.014) and the proportion of participants experiencing at least 1 severe hypoglycaemic 
event/12 months (χ2 = 7.7, p = 0.006). Correlation analysis failed to demonstrate a 
correlation between change in severe hypoglycaemia and change in any of the dietary 
variables (data not shown).   
 
Discussion 
The active promotion of dietary freedom alongside flexible insulin therapy education in 
adults with T1DM does not lead to increased dietary intake of energy or worsening of the 
nutrient profile.   
Despite the active promotion of dietary freedom, significant reductions in energy intake 
were observed, which appear to be derived from reduced protein and carbohydrate intake.  
Increased use of intensive therapy followed the release of the DCCT findings, however the 
majority of participants attending this structured education program were not practicing 
flexible insulin therapy pre course. At baseline, participants often reported management 
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that was based on a prescribed carbohydrate portion meal plan, and many were advised 
to consume carbohydrate at all meals and snacks.  Flexible therapy education facilitates a 
flexible carbohydrate intake, encouraging participants to be guided by appetite, rather than 
a specific carbohydrate portion meal plan.  The flexible insulin therapy curriculum 
facilitates a reduction in carbohydrate intake by a number of means, including; participants 
learn to dose for lower carbohydrate or carbohydrate-free meals; basal titration eliminates 
the need for regular snacks; and strategies for physical activity encourage insulin reduction 
options where weight loss is desired, reducing the reliance on carbohydrate 
supplementation.    The observed reduction in carbohydrate and energy may also be due 
to intentional energy restriction, given that more than half of the participants expressed a 
desire to lose weight.  The small reduction in fibre is not surprising, given the reduction in 
carbohydrate intake, and though the magnitude of the reduction is not clinically relevant, 
the poor achievement of fibre recommendations is a concern that has been identified 
previously in other cohorts with T1DM 4,5,7,22,23.  Dietary intake data from the Eurodiab 
IDDM Complications study  found higher intakes of fibre to be independently related to 
beneficial trends in serum lipoprotein profiles in men and lower CVD risk in women 23. The 
small reduction in protein suggests a ‘whole food’ change’ rather than merely reduction in 
simple sugars and would be expected with reduced snacking (often with bread and cereal 
products) or deliberate energy restriction for weight control.  The significant reduction in 
carbohydrate and energy intake, without increasing hypoglycaemia, indicates that the 
program has enabled participants to eat less, in a safe manner.  Anecdotally, it was noted 
that for many participants, the ‘freedom to eat’ message has been interpreted as the 
freedom to ‘not eat’ or to ‘eat less’ or snack less, rather than eat more. 
Despite  a statistically significant reduction in energy intake from baseline to 12 months, 
weight and BMI reductions were not detected in this cohort, however an audit of Australian 
DAFNE centres conducted by McIntyre and colleagues demonstrated a statistically 
significant  weight loss (0.9 kg) in a larger cohort of 145 participants 13.  In the setting of 
intensive insulin therapy and improved glycaemic control where studies such as the 
DCCT24 suggest the  potential for weight gain, this is considered clinically relevant.  The 
failure to detect weight loss in this cohort may be due to inadequate statistical power 
related to sample size.  
Other studies that have examined dietary intake in the setting of flexible insulin therapy 
with a focus on carbohydrate counting, have also found dietary intake to be unaffected by 
increased insulin flexibility.  Boulin and colleagues examined dietary intake in 72 children 
and found no difference in energy and macronutrient intake in children on fixed meal plans 
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compared to carbohydrate counting and flexible MDI25.  Peters and colleagues 26 observed 
dietary intake in 28 adolescents progressing from less intensively manage diabetes to 
insulin pump therapy  and found that energy intake was reduced in the short term (3 – 6 
months), but unchanged in long term follow up (18 months) and macronutrient intake was 
unchanged.  The authors reported that commencement of insulin pump therapy was 
associated with reduced snacking.  The low adherence to dietary guidelines appears to be 
widespread across fixed and flexible therapy 27-30, and comparison with control groups 
highlights that diet quality in those with T1DM is often poorer than in controls 27,29,30.  
Despite the widespread difficulty in achieving dietary guidelines, education programs 
focusing on healthy diet education alongside carbohydrate counting and flexible insulin 
therapy have been shown to improve dietary intake, specifically in reducing energy, and fat 
and increasing fibre intake 31,32. 
 
The main weakness of this study is the potential for diet history under-reporting.  
Underreporting of dietary intake is has been observed in women, and in those who are 
overweight or have previously exercised dietary restraint 33.    Given that this cohort is 
predominantly (70%) female and that 52% of participants had a BMI in the overweight & 
obese range, some degree of underreporting is likely.  More than half of the participants 
reported a weight loss intent, therefore it is difficult to separate under-reporting with 
deliberate dietary restriction.   However the diet history interview enabled a trained dietitian 
to extend questioning to qualify the responses when dietary recall suggested implausible 
nutrient intakes.  Validation studies of the diet history technique have demonstrated good 
agreement in energy intake using dietary history methodology, with only 4.6% under 
reporting when compared to double labelled water derived energy intake 34, supporting the 
validity of diet history methodology to assess energy intake.  Short and long term 
reproducibility of the diet history method has been demonstrated by Schmidt and 
colleagues, who assessed mean intakes and correlation coefficients between diet history 
interviews, conducted 12 months apart, in 50 adults with T1DM35.  No difference was 
observed in energy or macronutrient intake between the 2 interviews and within subject 
correlations were 0.6 – 0.7 suggesting  that any mis-reporting with DH methodology is 
likely to be systematic and supports use of the DH methodology  in a pre-post study 
design to identify changes in nutrient intake.     
Sample size is also a potential weakness of the audit and limits the ability to detect small 
changes in dietary intake.  Post hoc analysis indicates that with 46 participants, changes in 
fat and saturated fat in the order of 2.9% and 1.5% respectively are able to be detected, 
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ruling out larger increases in fat intake in this setting.   The high loss to follow up (39%) is 
also a concern, with the cohort lost to follow up characterized by shorter duration diabetes 
and poorer control.  It possible that this study retained participants with improved 
compliance with diet, as dietary compliance has been seen to be associated with lower 
HbA1c 36.   Participants who are non-compliant with dietary advice may demonstrate 
worsening dietary intake following advice on increasing dietary freedom, however given 
the observation of a small, but significant weight loss and neutral impact on blood lipids in 
the larger scale Australian audit13, it doesn’t appear that dietary fat or energy intake 
worsen.  The loss of those with higher HbA1c is expected to dilute impact of this education 
on improvement in HbA1c, given that greater reductions in HbA1c are seen in those with 
higher baseline values.  
 
This report confirms that adults with T1DM attending flexible insulin therapy education 
have similar difficulties as other T1DM populations in achieving dietary guidelines. 
However, when flexible insulin education is delivered with an active promotion to eat 
freely,  dietary intake does not appear to ‘worsen’.  Instead, there is greater freedom to ’eat 
less’ either at meals or snacks, resulting in a reduction in carbohydrate, protein and energy 
which may assist with weight loss efforts, without increasing hypoglycaemia.  Given the 
heightened risk of cardiovascular disease in diabetes, efforts to achieve dietary guidelines 
should continue to be an important part of dietary education, and active promotion of the 
dietary guidelines alongside flexible insulin therapy education may be one way to address 
this widespread problem. As flexible therapy for the management of T1DM becomes more 
mainstream and there is a move away from dietary prescription, future research into 
dietary quality, including micronutrient and fibre intake  may provide valuable insights to 
improving dietary quality and achievement of nutrient recommendations. 
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Tables and Figures 
Table 1:Diabetes nutritional recommendations  
Nutrient  EASD WHO/FAO 
Protein %  10 – 20*  
Carbohydrate %  45 – 60  
Fat %  ≤ 35 
≤ 30 if overweight 
<35% 
Saturated fat %  and 
trans fats 
< 10% saturated + trans 
fatty acids 
 
If high LDL cholesterol 
<8% saturated fat + trans 
fats  
< 10% 
< 7% high risk groups 
Polyunsaturated fats % ≤ 10 6 – 10% 
Monounsaturated fats 
%  
10 – 20  15 – 30% 
Cholesterol mg/d  < 300   
Fibre g > 40g/day or 
>20g/1000kcal/d 
 
Alcohol g/d 10† - 20‡  
* Where there is nil evidence of nephropathy.  Gender specific recommendation represented as †for women 
and ‡ for men .  EASD = the Diabetes Nutrition Group of the European Association for the Study of Diabetes, 
WHO/FAO = joint World Health Organisation/Food and Agriculture Organisation expert consultation. 
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Table 2:  Baseline characteristics of those who attended 12 month follow up versus non 
attenders. 
Baseline Variable Attenders 
N=46 
Non-attenders 
N=29 
P value 
Metabolic/Anthropometric    
Women (number, %) 32 (70) 25 (86)  
Age (years) 40 (29-51) 37 (26 – 44) 0.366 
Diabetes duration (years) 20 (11-26) 9 (7 – 17) 0.002 
BMI (kg/m2) 25 (23-28) 26 (23-30) 0.147 
HbA1c  (%) 7.8 (7.1-8.5) 8.5 (7.6-8.9) 0.147 
HbA1c (mmol/mol) 62 (54-69) 69 (60-74) 
SH frequency 0 (0-1) 0 (0–2) 0.548 
DKA frequency 0 (0-0) 0 (0-0) 0.592 
Dietary intake    
Energy (kcal/d) 1756 (1521-1931) 1893 (1515-2105) 0.638 
Protein % 21 (± 3) 20 (± 4) 0.377† 
Fat % 32 (± 7) 31 (± 6) 0.529† 
Carb % 42 (± 7) 45 (± 7) 0.887† 
SFA % 12 (10-14) 12 (7-14) 0.775 
PUFA % 5 (4 – 5) 4 (3-6) 0.214 
MUFA % 12 (11-14) 11 (10-13) 0.426 
Chol (mg/d) 208 172-329) 233 (165-304) 0.816 
Fibre (g/1000kcal) 13 (12-16) 12 (11-15) 0.085 
BMI = Body mass index, HbA1c = glycosylated haemoglobin, SH = severe hypoglycaemia over 12 months, 
DKA = diabetes Ketoacidosis frequency over 12 months, Protein % = protein % of total energy intake (TEI), 
Fat % = fat % of TEI, Carb% = carbohydrate % of TEI, SFA = saturated fatty acid % of TEI, PUFA = 
Polyunsaturated fatty acid % of TEI; MUFA = monounsaturated fatty acid % of TEI, Chol = cholesterol. 
†Normally distributed variables compared using independent t-test, otherwise Mann Whitney U test used. 
Normally distributed variables described as mean (± SD), otherwise as median (IQR). 
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Table 3. Pre and post course dietary analyses in 46 adults. 
 
Pre course 12 months 
post course 
Change 95%CI or 
Median change 
IQR 
P 
value 
Protein (% TEI) 21 (± 3) 21 (± 4) -0.2 -1 , 1 0.713 
Carbohydrate 
 (% TEI) 
42 (± 7) 42 (± 7) 0.2 -2 , 3 0.892 
Fat (% TEI) 32 (± 7) 34 (± 7) 2 -0.2 , 4 0.074 
SFA (% TEI) 12 (10-14) 12 (10 – 15) 0.9 -1 - 3 0.286 
PUFA (% TEI) 5 (4  – 5) 5 (4 – 6) 0.1 -1 - 1 0.323 
MUFA (% TEI) 12 (11 – 14) 12 (11 – 15) 0.2 -2 - 2 0.136 
Fat (g/d)  65 (49 –78) 62 (49 – 79) 3 -16 - 10 0.206 
Cholesterol 
(mg/d) † 
208 (172 – 330) 211 (179 – 269) -8 -68 - 37 0.159 
Carbohydrate 
(g/d) †  
198 (163 – 238) 162 (143 – 204) -30 -48 - -19 <0.001 
Energy (kcal/d) 
1799 
 (1521 – 1931) 
1592  
(1378 – 1940) 
-162 -459 - 57 0.002 
Fibre 
(g/1000kcal) † 
13 (12 – 16) 13 (11 – 15) -1 -4 - 1 0.047 
Alcohol (g) †‡ 4 (0 – 11) 4 (0 – 14) 0 -1 - 4 0.251 
%TEI = % total energy intake. SFA = saturated fatty acids.  PUFA = polyunsaturated fatty acids.  MUFA = 
monounsaturated fatty acids.  Normally distributed data are presented as mean (±SD),and mean change 
variable and 95% confidence interval is shown,  otherwise median (IQR), median change and median 
change IQR is shown.   Paired baseline and 1year data for primary outcome variables were compared using 
the paired t test for normally distributed change variables and †Wilcoxon Matched Pairs Test for the 
remainder.  ‡Paired data available for 36 participants. 
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Discussion and implications of findings Chapter 2 
 
This study describes the first quantitative assessment of energy and macronutrient intake 
in adults with T1DM following DAFNE education.  We found that the ‘freedom to eat’ 
message was interpreted by many as a ‘freedom to eat less’, with reduced energy and 
carbohydrate intake and no increase in hypoglycaemia. The ability to eat less and snack 
less may be beneficial towards weight control efforts, without increasing the risk of 
hypoglycaemia.  The predominance of females in the study sample may suggest a greater 
bias towards ‘eating less’, however it was observed that both males and females found the 
freedom to eat less to be a positive attribute, in terms of weight management, as well as 
lifestyle freedom (not having to eat meals or snacks at a predetermined time) and while 
exercising (not always having to eat before/during exercise, after learning about insulin 
reduction strategies). 
 
The loss to follow up of 39% of the cohort is not unusual, given the ‘tendency’ for attrition 
seen in both the UK (with retention of 55% of participants 12 months post course) and 
Australian setting (with retention of 35 – 53%).  This may be due to the ‘one off’ nature of 
the education program (delivered over 1 week) with structured follow up at 6 weeks and 6 
months post course.  This may not be adequate follow up to maintain ongoing contact with 
participants.  
 
This study adds to one existing report that described the qualitative assessment of eating 
behaviour following DAFNE participation, demonstrating that eating behaviour is 
unchanged post course. 
 
When this study was first conducted, nutrition guidelines had not been published for the 
Australian setting and local diabetes centres deferred to nutrition guidelines from the 
EASD or American Diabetes Association.  In 2011 the NHMRC guidelines were  released 
for Australian centres, with similar macronutrient recommendations as the EASD 
guidelines. 
 
This study also confirms the poor achievement of nutritional recommendations and future 
studies incorporating flexible insulin self-management with promotion of healthy eating are 
warranted. 
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Abstract  
 
Background 
 
Modern flexible multiple daily injection (MDI) therapy requires people with diabetes to 
manage complex mathematical calculations to determine insulin doses on a day to day 
basis.  Automated bolus calculators assist with these calculations, add additional 
functionality to protect against hypoglycaemia and enhance the record keeping process, 
however uptake and use depends on the devices meeting the needs of the user. We 
aimed to obtain user feedback on the usability of a mobile phone bolus calculator 
application in adults with T1DM to inform future development of mobile phone diabetes 
support applications. 
 
Methods 
Adults with T1DM who had previously received education in flexible MDI therapy were 
invited to participate.   Eligible respondents attended app education and one month later 
participated in a focus group to provide feedback on the features of the app in relation to 
usability for patient-based flexible MDI and future app development. 
 
Results 
Seven adults participated in the app training and follow up interview.  App features that 
support dose adjustment to reduce hypoglycaemia risk and features that enable greater 
efficiency in dose calculation, record keeping and report generation were highly valued. 
 
Conclusions 
Adults who are self-managing flexible MDI found the Rapidcalc mobile phone app to be a 
useful self-management  tool and additional features to further improve usability, such as 
connectivity with BG meter and food databases, shortcut options to economise data entry 
and web based storage of data, were identified.  Further work is needed to ascertain 
specific features and benefit for those with lower health literacy. 
 
Keywords: intensive management, diabetes technology, iphone, applications, self-
management 
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Background  
Self-management is the cornerstone of type 1 diabetes (T1DM) management and patient-
based flexible multiple daily injection (MDI) therapy requires the individual to perform a 
number of (often complex) mathematical calculations1.  To calculate the prandial insulin 
dose, the carbohydrate count must first be calculated for a range of foods, requiring 
individuals to interpret carbohydrate data from food labels, nutrition databases and other 
published sources.  Once the carbohydrate quantity is determined, the 
insulin:carbohydrate ratio is then applied, either by division or multiplication (depending on 
the method of carbohydrate counting). Subsequently, a dose correction is determined by 
subtracting target blood glucose (BG) from the prandial BG and dividing by the correction 
factor.  Numeracy skills are essential for effective flexible MDI therapy and lower numeracy 
scores are associated with lower self-efficacy and higher glycosylated haemoglobin 
(HbA1c)2,3. Sussman and colleagues compared manual insulin dose calculations to an 
automated bolus calculator (ABC), and found 63% of dose determinations conducted 
manually were incorrect compared to 6% of calculations via an ABC 4. 
Automated bolus calculators (ABCs) integrated with BG meters and insulin pumps have 
enabled safe and effective bolus determination as demonstrated by improvements in 1) 
glycaemic control 5-7,  2) treatment satisfaction 7,8, and 3) confidence in dose determination 
4,9 and reduction in 1) frequency10 and fear of hypoglycaemia 9, 2) dose calculation errors4 
and 3) treatment burden associated with mathematical calculations and record keeping 11.   
 
In addition to managing the prandial dose calculation, effective ongoing management of 
patient-based flexible MDI therapy requires the person with diabetes to undertake 
additional self-management tasks which add to the daily burden of diabetes management.  
These tasks include counting carbohydrates (which involves measuring foods, interpreting 
food labels, researching unfamiliar foods, performing an estimate of carbohydrate count 
when eating out), monitoring blood glucose levels (which involves washing hands prior to 
testing, taking care with meter and test strip handling, remembering to monitor prior to 
eating, pre bed, prior to driving and when feeling symptomatic with hypoglycaemia), learn 
the impact of physical activity and alcohol on blood glucose and make anticipatory 
adjustments, record BG and additional pertinent diabetes management information (such 
as carbohydrate, alcohol, activity, stress, illness) in a diabetes diary, and effectively 
collaborate with health professionals.   
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The BG or diabetes diary, which is often paper-based, is an essential component of 
flexible MDI, as it enables comparison to BG targets and enables BG trends to be 
analysed to inform proactive changes in insulin formula.  Despite the importance of the BG 
diary, compliance with BG diary recording is often poor 12.  Use  of an electronic hand held 
diary has been shown to improve compliance with record keeping, compared to the 
‘traditional’ paper-based diary13 and the combining of dose calculator and BG diary 
recording functionality may explain the satisfaction and preference for ABCs4. Some ABCs 
enable users to record additional pertinent data (such as exercise and illness), usually in 
pre-determined text format. Free text data recording is not available in ABCs.  
 
Integration of bolus calculator functionality into mobile phones has emerged, in some 
cases, with SMS messaging and telemedicine 14.  In addition to the dose calculator and 
BG diary functionality of ABCs, mobile phones have added advantage of ‘connectivity’, 
enabling more efficient communication of data with health professionals providing self-
management support.  Improved motivation, self-management reflection and 
communication between patient and health professional has been observed with use of 
mobile phone diary apps 15, highlighting the benefits of this technology in self-management 
support. 
 
In Australia, there are over 30 million mobile phones registered 16, which is more than one 
per person and approximately half (55%) use mobile phone apps 17. The ubiquitous nature 
of mobile phones ensures universal access to this technology, potentially enabling a 
greater number of individuals to access an ABC with BG diary features. 
 
The RapidCalc mobile phone app was developed locally, as an adjunctive tool to support a 
specific subset of adults with T1DM – those who have been trained in flexible insulin self-
management using carbohydrate counting and insulin:carbohydrate ratios.   The app has 
been developed specifically to provide a phone-based platform to support the following 
self-management practices: bolus dose determination (based on individual insulin 
adjustment algorithms), diabetes diary recording, report generation and communication 
with health professionals.  The app bolus calculation equation is consistent with ABCs, 
with the calculation for bolus doses determined from three calculations:  1) bolus for 
carbohydrate, based on insulin:carbohydrate ratio, 2) correction  bolus based on prandial 
glucose, insulin sensitivity and target BG and 3) insulin on board (IOB) based on residual 
insulin from previous bolus dose(s). Rapidcalc also incorporates the following features, 
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which differentiates it from ABCs: 1) free text option for recording pertinent details relating 
to a specific events, 2) food photograph option, that enables the user to save a food 
photograph, time stamped with the relevant carbohydrate count in the diabetes diary, 3) 
variable options for bolus adjustment for exercise, 4) ‘Reverse calculator’ which calculates 
the carbohydrate required when BG is below target, 5) omission of correction bolus for 
high BG due to an antecedent hypoglycaemic event, or when consuming a significant 
quantity of alcohol and  6) data export capabilities via email.    
 
 To our knowledge, there are currently no other phone-based bolus calculator applications 
which incorporate these features. 
 
The aim of this study was to obtain user feedback on the usability of the RapidCalc app in 
adults with T1DM already experienced in flexible MDI, with a view to informing further 
development of this application and identifying user preferences with this emerging 
technology. We sampled from graduates who had recently completed structured education 
in flexible insulin self-management education to explore the specific features that this 
specific type of insulin user would want from a phone based app to support day to day 
diabetes management.  
 
Methods 
 
Participants 
The interview group consisted of 7 participants who had previously received flexible MDI 
education program by attending the Dose Adjustment for Normal Eating (DAFNE) 
program.  The DAFNE program aims to equip graduates with evidence based insulin self-
management skills based on carbohydrate counting and insulin algorithms, and includes 
insulin adjustment strategies for physical activity, illness and when consuming alcohol, and 
pattern evaluation of BG trends to inform ongoing insulin adjustment to achieve target 
glucose levels.  Each DAFNE course is delivered in a group setting, over 5 consecutive 
days.  DAFNE graduates were chosen, firstly, as they have received the same insulin self-
management education and secondly, because they have had considerable experience 
contributing their opinion alongside others with T1DM in a group setting.  Graduates who 
had completed DAFNE education in the most recent 13 months were invited by email to 
participate.  The inclusion criteria were: age 18 – 65 years, access to an iphone or iPod 
touch, able to attend a 1-2 hr training session at study commencement and 1-2 hr group 
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interview at the end of the trial period, willingness to email RapidCalc results to the study 
centre once per week for the first four weeks of the study, using insulin Glargine (Lantus), 
Insulin Detemir (Levemir) or NPH (Humulin NPH, protaphane) insulin for basal insulin and 
Insulin Glulisine (Apidra), Insulin Lispro (Humalog) or Insulin Aspart (Novorapid) for bolus 
insulin, able to inject insulin for all meals and large snacks, able to test BG at least 4 - 6 
times/day, HbA1c  53 - 86 mmol/mol (7 – 10%), absence of end stage diabetes 
complications or other serious medical condition except for well managed coeliac disease, 
thyroid disease or asthma (not requiring oral steroids) and able to read and speak English.  
Criteria for exclusion were: hypoglycaemia unawareness, major psychiatric illness that 
prevents interaction in a group setting, pregnancy or breast feeding and use of an insulin 
pump. 
Procedures 
Four weeks prior to the app education session, participants were instructed by phone or 
email how to load the app on their phone.  Participants were asked to maintain a paper-
based BG diary for 4 weeks, with weekly transmission to the study coordinator.  The 
purpose of this was to support participants in optimising insulin algorithms prior to app use.  
App education session 
Education on the use of the app was conducted by the app developer in a group setting 
with all participants present.  A diabetes educator (BK) was in attendance to support 
programming of the app with each user’s existing insulin dose algorithms.  Participants 
started using the app following this session.  Participants were invited to contact the 
diabetes educator (BK) for assistance with dose adjustment at any time until the focus 
group meeting. One month after app education session, all participants were invited to 
return for the focus group.  
The focus group 
The focus group was led by a diabetes educator (MN) who was not involved in 
development of the app or in the app education session.  The open ended interaction of a 
group interview was chosen to stimulate thought and emotions, to reveal material which 
may not ordinarily be expressed in an individual interview.  A semi-structured interview 
format was used, focusing on the attributes of usability, which include learnability, 
efficiency, memorability, errors and satisfaction 18.  Interview prompts were devised within 
the research team, which was comprised of experienced clinicians and researchers and 
focus group questions are summarised in Appendix A.  The aim was to develop themes to 
address the aims of the study without being deemed leading or judgemental.  
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At this visit, app data exports (data reports which show data entered by each user) were 
obtained for each participant to identify the duration of app use. The interview was audio 
recorded, then transcribed verbatim.  Thematic analysis of the focus group followed the 
structured approach outlined by Braun & Clarke19 where themes were identified according 
to the group discussion and not limited to the usability attributes. Themes were coded 
according to specific app features to highlight the features that participants found useful or 
not.   The transcript was reviewed by two reviewers (BK & MN) independently, who met to 
address discrepancies and agree on themes.  
 
Results  
 
Fifteen DAFNE graduates were sent an invitation to participate and nine graduates 
expressed interest, however 2 were unable to participate due to scheduling  conflicts.  
Seven adults (5 female) with mean (SD) age of 36 (7) years and mean duration of 
diabetes 27 (7) years, attended app education and a 2 hour focus group.  Participant 
characteristics are summarised in Table 1.  Six of the seven participants used the app for 
the duration of the study period.  The one participant who had not used the app for the 
duration of the study indicated that she had failed to sustain regular BG monitoring during 
the study, therefore ceased using the app. 
 
Three main themes were identified from the focus group: 1) bolus calculator features and 
trust, 2) diabetes diary and report features and 3) satisfaction and control.  Within each 
theme,  sub-themes are described, with respondent quotes coded according to gender, 
number identifier, age category and diabetes duration:  for example, F5 (A40-44, D20 ) 
refers to female number 5, aged 40 – 44 years, with 20 years diabetes duration. 
 
Bolus calculator features and trust 
Users programmed the app with their personal insulin algorithms with the help of the study 
team and none of the group reported difficulty in the set up process.  Six participants 
reported that they trusted the accuracy of the dose calculation via the app, though five 
reported they like to ‘check the dose’ recommended by the app, against manual 
calculations.  One participant (F1, A35-39, D27) rarely checked the dose, acknowledging 
that "I'm one of those people in the population that would go, 'I don't have to think, just tell 
me what to have.' “  This person went on to add that she trusted the app more than her 
own calculations, claiming that “ the app is a lot more consistent than I am” and “It's better 
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than guessing in the complete dark - it's less dark."  She went on to acknowledge that her 
trust in the app meant that she didn’t check her ratios (confirm suitability of current dosing 
algorithms), which she admitted did not enable ‘fine tuning’ and ongoing dose adjustment. 
F5 (A30-34, D25) described how the app made it easier for her to remember the 
insulin:carbohydrate ratio to use for specific meals, especially after a change in 
prescription for insulin:carbohydrate ratio. 
Four participants described over-riding the dose, not because of a lack of trust, but for 
specific reasons, such as when physically active or when snacking.  There was group 
agreement with F5 (A30-34, D 25), who reported "It's not that I don't trust it, it's just that I 
need to over-ride it."  M1 (A30-34, D26) highlighted the problem with the pre-set time 
frames for dose algorithms in the app:  "My ratios didn't fall into time frames provided by 
the app.  I usually use the 1:1 ratio at lunch and a 2:1 ratio in the evening, so......if I had a 
snack in the afternoon, I usually use the 1:1.... but if I have the snack between 4 and 5 
(pm) and that falls within the dinner... so I would be ignoring the dose that it was 
calculating because I thought no, that is twice as much as I want to be having."  The 4 
participants who had to override the app due to pre-set time frames for the insulin 
algorithms stated a preference for customisable time settings for insulin algorithms. 
 
Three participants found the IOB feature useful in reducing the risk of hypoglycaemia.   F1 
(A35-39, D27) described this feature as "The best thing in the world."  Though considered 
useful, many found that the IOB was misleading when meals and snacks were eaten in 
close proximity.  The IOB is calculated based on total residual bolus insulin, therefore may 
overestimate the IOB in instances where meals/snacks are eaten in close proximity.  Five 
participants agreed that they needed to over-ride the bolus suggestion when meals were 
consumed in close proximity. 
The reverse calculator, which determines the carbohydrate to be consumed for BG below 
target, was used by 4 participants.  Two users described specific instances where this 
feature protected against hypoglycaemia, or prevented over-treatment of hypoglycaemia.  
F3 (A30-34, D21) states, "What I love… was that it told me how much to have and I didn't 
overeat.  The number of times that I overeat from hypos is ridiculous; it would be 99% of 
times.”  Four participants reported that the carbohydrate supplementation suggestion from 
the reverse calculator tended to be lower than their usual guidelines for hypoglycaemia 
management (15 g rapid acting carbohydrate).  M2 (A30-34, D26) was particularly 
concerned when the app suggested dosing insulin for some of the hypo treatment: "Cause 
I found when I would be 3.4 or 3.3 (mmol/l), the DAFNE rules would say 1.5 CPs 
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(carbohydrate portions) and I'd put in 1.5 CPs and it would be telling me to take one unit of 
insulin, which I obviously wasn't going to do.” 
 
The exercise bolus adjustment feature, which can be programmed to reduce the bolus 
dose in the setting of physical activity, had been used by 4 participants. All agreed that 
adjusting insulin to manage BGLs around exercise was challenging. F4 (A30-34, D20) 
sums up her experience with the exercise feature, “I don't know how I'm reacting to 
exercise because I don't pay enough attention to it” and F2 (A35-39, D34), "I always muck 
it up somehow.  I never seem to crack it.”  There was general agreement that exercise 
planning was difficult and that in order for “any app to work,” each user had to first 
understand their own exercise effect and develop management strategies with 
carbohydrate supplementation and/or insulin reduction. Two of the group reported that 
they used the exercise feature regularly: that it was beneficial and that the feature served 
as a prompt to think about changing bolus doses when they were more physically active 
than usual.  Three participants agreed that a basal dose adjustment prompt for prolonged 
exercise would also be helpful in instances where exercise is of long duration.   
 
The alcohol bolus adjustment feature, which withholds the correction bolus after alcohol 
consumption, was considered by the group as an important feature, however there was 
disparity in the quantity of alcohol that represents the threshold for when this feature 
should be chosen.  All users agreed that being able to record alcohol consumption (even 
for small quantities, when no dose change was programmed) was important, to enable 
reflection on the effect of alcohol on BG levels. 
 
Blood glucose data is entered manually into the app to determine the bolus dose.  The 
entire group agreed that it would be beneficial to have a BG meter that could  transmit 
glucose data directly to the app, eliminating the need to manually enter glucose data into 
the phone.  Responses to this option were “That would be brilliant”; “I would do a dance 
about that one" and "That would be awesome" emphasize the overwhelming desire for this 
feature. 
 
Diary report features 
There was an overwhelming group consensus that the app was a ‘great’ record keeping 
device, due to 1) the convenience of entering data onto a smart phone and 2) the fact that 
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participants were rarely without their phone, enabling “better record keeping” compared to 
previous diary methods and other apps that participants had used. 
Participants expressed the desire to retrospectively edit data pertaining to their diabetes 
management or food consumed.  M1 (A30-34, D26) described, "It drives me mad how you 
can't put an entry in after (an event) at any time of the day. Then I don't bother putting it in. 
You just wouldn't do it: (you) just forget about it."  There was also a consensus that the 
ability to record a ‘true’ account of diabetes management history (using free text options) 
and record pertinent events was a valuable feature.  Participants raised the idea of a 
‘shortcut’ button to enable easy recording of a pre-determined list of events, in addition to 
the current free text option, to record what they considered to be pertinent and useful 
information, when later reviewing BG trends.  To further individualise the app, many felt it 
would be useful to be able to personalise screen displays by allowing removal (or cloaking) 
of features to simplify the user interface. 
 
Three participants found the Rapidcalc method for creating diabetes diary reports, using a 
macro to convert raw data into a diabetes report was difficult, and that not being able to 
easily generate this BG diary data for their treating clinician was a problem.  The group 
agreed that web based storage of settings and BG diary data would be a more effective 
way to manage their diabetes diary, both for their own reflection and when consulting their 
health care provider.  Some participants referred to web based storage of other phone 
data and that web based storage of the RapidCalc settings on the phone would also be 
useful to ensure data safety in the event of loss of device. 
 
There was group agreement on the desire for food database connectivity, to assist with 
carbohydrate counting and enable foods consumed to be easily recorded in the diabetes 
diary.  Some participants suggested that it would be helpful to ‘register’ favourite foods in 
the set up process, enabling favourite foods to be recorded in the diary via a shortcut 
menu.  Participants also felt that it was important to capture specific information about food 
when reviewing BG trends and some had used the photograph feature for this purpose. 
 
Satisfaction and control 
There was group consensus that the app made bolus calculation easier and quicker, with 
one participant (F1, A35-39, D27) reporting that "the application worked for me in that 
there was less thinking involved" and that BG control improved from the start of app use.  
The group agreed that the app provided an improved means of diabetes record keeping 
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compared to previous methods.  Two participants also reported improved BG control since 
using the app.  
Three participants, reflected on improved satisfaction, compared to their experience with 
other apps.  F1 (A35-39, D27) reported. “I was using another diabetic app and it wasn't 
maintainable for me” and F5 (A30-34, D25), “I find (the app) so user friendly compared to 
other apps.”  M1 (A30-34, D26) reported, "I quite enjoyed using it," and F1 (A35-39, D27), 
"It has offered me something that nothing else in my busy-ness and my avoidance has 
offered me. " The entire group found the app to be a useful adjunct to their diabetes 
management and a number reported they enjoyed using it. 
 
Discussion  
 
Users of the Rapidcalc app developed a trust in the app calculation rapidly and described 
improved efficiency and efficacy of day to day insulin management compared to other 
methods of dose calculation and recording, and recommendations to further improve 
usability and reduce the burden of management were identified. 
 
The attributes of usability for which the group were able to give feedback were errors, 
efficiency and satisfaction.  Errors were not detected and trust in the app dose calculation 
was determined early due to ‘dose checking’ against manual calculations, which the users 
were accustomed to doing prior to app use.  Early establishment of trust in the dose 
calculation may be due in part also to the way that the components of the bolus dose are 
displayed on the screen, enabling quick verification of bolus dose components and total 
dose.  This is in contrast to Shepard and colleagues 20, who found that pump users did not 
trust an ABC (the Personalised Glucose Advisory System) when they could not determine 
how the dose was calculated. The issue of over-riding the app bolus calculator dose 
highlights the knowledge and experience in this cohort to understand other factors that 
impact on BG levels and reflects the active role these users take in the insulin dose 
adjustment process. Users who lack the knowledge and experience to confidently verify 
bolus insulin doses may not develop trust as readily. 
 
Users commented on the quick and easy access to dose calculation and diary recording 
on a device that most people carry on their person, suggesting greater efficiency 
compared to alternative devices, and suggestions were offered to improve efficiency 
further.  Features that could ‘save time’ and reduce hypoglycaemia risk were valued and 
39 
 
the specific app features identified as useful were IOB, reverse calculator, exercise and 
alcohol bolus modifiers and phone-based BG diary.  Though this was not measured, 
improved glycaemic control was also reported by some participants. 
 
Users were able to give feedback on learnability in the setting of optimal access to health 
professional support.   With appropriate training, users found the app easy to learn and 
use.  First time users who do not have health professional support may struggle with 
learnability, especially if they are not familiar with flexible MDI strategies, such as 
carbohydrate counting and use of insulin dose algorithms, as the app requires the user to 
input specific insulin algorithms based on carbohydrate counting.  Given that this app 
advises insulin dosing, it is expected that users would collaborate with their health 
professional in the programming and familiarisation process.  Participants felt that they 
could not comment on memorability as they had not experienced resuming app use after a 
period of discontinuance. 
 
Much of the discussion focused on app features that the group found useful and how the 
app could be further improved.   The IOB feature is a novel concept for those who had not 
used an ABC previously and there was a positive response about the benefits of this 
feature in reducing hypoglycaemia risk.  The reverse calculator was seen to be beneficial 
in controlling the tendency to ‘over treat’ hypoglycaemia.  Over treatment of 
hypoglycaemia is a common practice and impacts negatively on HbA1c21.  The 
discrepancy between ‘usual’ hypoglycaemia management protocol and the calculation 
from the app is not surprising, given that the standard treatment for hypoglycaemia is 
based on a low glucose threshold (3.5 mmol/l) and fixed quantity of carbohydrate (15g), 
whereas the app mathematically calculates the relative carbohydrate quantity required to 
return the BG to target range. This issue is likely to be a concern with other users as well 
and highlights the importance of hypoglycaemia management education.  
 
The bolus adjustment feature for exercise and alcohol were found to be helpful in reducing 
hypoglycaemia risk in those who used these features, though users felt that the threshold 
for bolus reduction in the setting of alcohol consumption needs to be individualised.   
Regarding bolus modifications for exercise, there was an overwhelming consensus that 
BG management around exercise was difficult and that individual requirements for 
exercise needed to be established before being confident to use the app to modify insulin 
doses for exercise.  Users found that the exercise and alcohol bolus adjustment features 
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served as useful prompts to ‘consider’ dose adjustment in these settings. Fully adjustable 
time frames were also preferred, to enable dose algorithms to be tailored to individual 
requirements for meals and snacks.  Pre-set time frames for insulin algorithm settings 
appeared to increase the burden of dose determination in individuals who use varied 
algorithms through the day. 
 
The idea of connectivity between the app and food composition databases, to enable 
carbohydrate data to be sourced and recorded, was favoured by the group: a preference 
that has been demonstrated in other reports15,20.   Connectivity with the internet was also 
favoured by the group, as a means to enable the diabetes diary data to be ‘securely’ 
stored and potentially able to be accessed remotely by health professionals.  
 
Users placed high value on the diabetes diary and felt that it should reflect a full and true 
account (including retrospective data edit capability) of diabetes management, confirming 
that users consider a comprehensive diary to be a valuable tool in their diabetes 
management.  This desire to retrospectively edit diabetes diary data has also been 
reported by Arsand and colleagues 22. Users felt it was important to record all data they 
perceive to be pertinent, either by free text or with ‘personalised’ buttons to ‘economise’ 
data entry.  Users of the Personalised Glucose Advisory system 20 also reported that the 
bolus calculator should take into account and record a broad range of factors affecting BG 
levels, such as physical activity duration and intensity, consumption of higher protein and 
higher fat meals, hormonal changes relating to the menstrual cycle, breastfeeding, stress, 
shift work and alcohol consumption.  The concerns about data safety and having easy 
access to diary data lends further support to the importance that users place on diabetes 
diary data and the sharing of this information with health care professionals. 
 
Lawton & colleagues 11 voiced the concern that some users of ABCs will fail to verify bolus 
doses or reflect on glycaemic outcomes to inform ongoing insulin dose titration. This is a 
valid concern.  ‘Dose checking’ did drop off in this cohort, as seen in the Lawton cohort, 
however one would expect this attrition, given that users have confirmed that the 
calculations can be trusted.  In this cohort as well as Lawton’s, individuals were identified 
who exhibited either a ‘blind trust’ in the bolus calculator, or did not know how to adjust the 
insulin algorithms, which is a concern if the algorithms are not optimised.  Lawton’s 
concern that dependency on the bolus calculator may lead to deskilling, abandoning 
diabetes diary reflection and proactive titration of insulin doses and reliance on the bolus 
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calculator, leaving users potentially unable to determine doses in the event of meter failure 
is also valid and highlights the importance of ongoing education and support, before and 
after the introduction of ABC’s. 
 
A recurring theme across a number of features was the desire for functionality that 
reduces the burden of day to day management: in diabetes diary recording and 
carbohydrate counting, with shortcut buttons and BG meter and food database 
connectivity, personalisation of user screens and easier access to BG diary data.  This 
highlights that role that ABCs can play to reduce the burden of day to day management, 
however care should be taken to ensure that ABCs are not offered in place of structured 
education in insulin self-management, a process that is difficult to ‘short cut’.  Others have 
stressed that when ABCs are used, comprehensive education in flexible MDI should 
remain the key focus of self – management 11,23, with education and support on ABC use 
delivered by health professionals familiar with ABC functionality.  Structured education and 
ongoing support for flexible MDI using an ABC should include, at the very least, the 
following: 1) appropriate education on patient-based flexible MDI, including carbohydrate 
counting , 2) comprehensive education on programming and use of the dose calculator, 
delivered by health professionals experienced with these devices, 3) pattern evaluation 
education using the bolus calculator diary and graphs and 4) regular and ongoing insulin 
optimisation support from health professionals experienced in use of ABCs and a meter 
failure plan. 
 
Limitations 
The main limitation of this study is the small number of participants and one focus group.  
We deliberately targeted adults with T1DM who were managing their diabetes in a specific 
way, using advanced skills that require a certain degree of health literacy and self-directed 
care.  Using DAFNE graduates ensured that all participants had received similar flexible 
MDI education, enabling us to focus on the patient experience with the app in those who 
have received flexible MDI self-management education.  All DAFNE graduates have 
experienced nearly 40 hours of group interaction and hence we were confident of the 
ability of focus group participants to not be ‘led’ by others in the group, or for the group to 
be dominated by any individual.  Despite the small number of participants, we feel 
feedback from this focus group has yielded valuable user experiences on specific app 
features in individuals self-managing flexible MDI.  We are not able to comment on the 
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usability of this app for other patient groups, where flexible MDI education has not been 
provided, or in those with low health literacy. 
 
The recruitment of DAFNE graduates yielded a cohort that is more confident with 
carbohydrate counting and patient-based insulin adjustment and the trust in the app 
calculation and willingness to over-ride the bolus suggestion for special circumstances 
observed in this cohort is most likely enhanced by a familiarity with insulin adjustment 
terminology and patient-based insulin dose adjustment strategies. The process of 
confirming the dose calculation and over-riding a dose based on prior experience may not 
apply to users who are not confident with insulin dose adjustment strategies and this may 
have an eroding effect on confidence and willingness to use the app in instances where 
adequate education and support are not available.   
 
The focus group participants all had long standing diabetes (average 27 years, range 20 – 
38 years), however, this selection bias is not expected to impact on how the app may be 
perceived or used.   Those newly diagnosed with T1DM are taught similar concepts in 
patient-based insulin optimisation from diagnosis, hence are also expected to be able to 
successfully use the app, providing insulin algorithms are adjusted as insulin requirements 
change during the honeymoon phase. 
 
The short duration of follow up limits the ability to comment about retention or efficacy of 
this device when it is no longer novel or resumption of app use after a period of 
discontinuance.  Given that the app performs the dual function of dose calculation and 
diabetes diary recording and has the potential to reduce the burden of diabetes 
management, we feel that users who are motivated to self-manage patient-based flexible 
MDI and maintain a diabetes diary will continue to use this app in preference to paper-
based approaches and other mobile phone apps currently available. For those resuming 
app use after a period of discontinuance, the ‘help’ screens within the app may assist with 
memorability.  The inclusion of pattern recognition software has been suggested 11 and 
this may reduce attrition associated suboptimal control due to inappropriate insulin 
algorithms. 
 
Flexible MDI therapy is also taught outside of the DAFNE program24-26, and though there 
are differences between programs in terms of mode of delivery and course duration, these 
programs all address what are considered to be the ‘core’ elements of insulin self-
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management education, namely, carbohydrate counting, insulin dose algorithms, 
adjustment for illness and exercise and proactive dose adjustment of insulin algorithms, 
and programs generally require users to manage dose calculations manually27.   We feel 
that the insights from this focus group can be extrapolated to other patients who have 
received flexible MDI education outside of the DAFNE program. 
 
Insulin users with low health literacy may gain as much, or greater benefit from using a 
phone app for dose calculation, to reduce risks associated with dose calculation errors and 
improve communication of data with health professionals.  As with this study cohort, care 
would need to be taken to ensure that the appropriate carbohydrate counting education is 
provided, however modifications to the app, such as pattern recognition and prompts to 
contact health professionals are potential exciting directions for future research with a 
broader user group. 
 
Conclusions  
 
Overall, users were satisfied and enjoyed using the app to manage their diabetes and trust 
in the bolus calculator was developed relatively quickly.  The ability to maintain a true and 
complete diabetes diary that enables users to record a range of factors in daily 
management is important to adults with T1DM who are actively engaged in their insulin 
self-management.  Features such as personalised user screens, shortcut buttons for data 
entry, and food database and meter connectivity, were highly valued for their potential to 
reduce the burden of day to day management.  Also favoured were options to increase 
accessibility to a full and accurate account of diabetes management in the diabetes diary 
that is easily accessible to users and their health professionals.  The importance of 
comprehensive education, both in terms of patient-based insulin dose determination, as 
well as ongoing dose titration is not diminished or substituted by use of a bolus calculator.  
These devices should be considered as tools to reduce the burden of flexible MDI and 
should supplement sound flexible MDI education. 
 
This focus group has provided valuable insights into the features of a smart phone-based 
app that adults with T1DM feel are important to support effective patient-based flexible 
MDI. Longer term follow up of patient experience and clinical efficacy of mobile phone 
apps incorporating these features warrants further investigation. 
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Tables and Appendices 
 
Table 1: Participant characteristics 
Participant 
number 
Age 
(years) Gender 
Diabetes 
duration (years) 
1 30-34 F 20 
2 30-34 M 26 
3 30-34 F 21 
4 30-34 M 25 
5 30-34 F 27 
6 35-39 F 34 
7 50-54 F 38 
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List of abbreviations 
ABC automated bolus calculator 
BG  blood glucose 
CP carbohydrate portion 
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DAFNE Dose Adjustment For Normal Eating 
HbA1c glycosylated Haemoglobin 
Hypo hypoglycaemia 
IOB  insulin on board 
MDI multiple daily injection 
T1DM  type 1 diabetes mellitus 
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Discussion and implications of findings Chapter 3 
 
The rapidcalc iphone app was developed by Gilport Enterprises 
(http://www.gilport.com/rapidcalc/index.html) in collaboration with myself, with the specific 
aim of providing a multi-purpose phone-based app to assist people using flexible MDI 
therapy. The DAFNE cohort was identified as a patient group who would be ‘optimally’ 
trained in using flexible MDI strategies, hence the collaboration with myself as a DAFNE 
facilitator in developing the clinical parameters of this app. 
 
This study sought to identify the specific features of a novel iphone app that would support 
adults in managing the myriad of tasks required to successfully self-manage intensive MDI 
therapy.  We found that users who were self-managing MDI therapy were highly engaged 
in their diabetes management and valued app features that enabled safe dose calculation, 
accurate and comprehensive diary recording and diabetes diary reporting that was secure 
and able to be communicated with health professionals.   App features unique to this 
device, which users found useful were, the reverse calculator, insulin reduction advice 
following alcohol consumption or after hypoglycaemia and free text options for data entry.  
Users preferred using the app to other phone-based diabetes apps, and further 
customisation to reduce the burden of record keeping, and functionality to improve data 
safety and connectivity with other apps were identified for future app development.  
Additional directions for future development include evaluation of this app in insulin-users 
with limited numeracy.  Connectivity with BG meter and food database would reduce the 
burden of data entry by the patient, as well as reduce the undue risk of medication errors 
in individuals with reduced numeracy.  This device has the potential to support patient-
based management of insulin therapy in individuals who may have previously relied on 
health-professional-centred direction for insulin management and the improved 
communication with the diabetes diary opens up viable alternatives to patient support, 
outside of the traditional clinic visit. 
 
Outside of the DAFNE setting, the app may also be useful to support flexible MDI therapy, 
however care must be taken in patient selection to ensure that users have some basic 
understanding of carbohydrate counting and  insulin action and algorithms.  This app is not 
considered as a ‘stand-alone’ tool to be used ‘in place’ of basic diabetes education, as 
errors in either carbohydrate count or accidental mistakes in app programming may result 
in insulin dose errors. 
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Planning is currently underway to evaluate the app in a clinical trial with a larger patient 
group, taking into account additional outcome measures, including glycaemia.  This will 
also enable assessment of the app in users who have not received the 
structured/extensive diabetes education that is the hallmark of  DAFNE course.
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Title Evaluation of psychosocial outcomes in adults with Type 1 diabetes following 
participation in a novel ‘short course’ structured flexible multiple daily injection (MDI) 
therapy self-management program. 
 
Abstract 
Objectives 
To evaluate the psychosocial impact of a novel education program, comprised of an 
abbreviated curriculum based on the ‘core elements’ of insulin self-management 
education, with a view of identifying education options for those unable to attend a 5-day 
Dose Adjustment for Normal Eating (DAFNE) program. 
 Methods 
The program was developed by DAFNE course facilitators and trialled using participants 
naive to flexible MDI education. Post course treatment satisfaction, wellbeing and diabetes 
distress were compared to baseline. 
Results 
Twenty one adults attended the program and sixteen participants returned 3 months post 
course.  Significant improvements were seen in W-BQ12 total score, PAID score and 
DTSQ, equivalent to that observed following participation in the 5-day program. 
Conclusions 
Short-course flexible MDI education is well tolerated by adults with T1DM with 
improvements in treatment satisfaction and psychosocial outcome that are consistent with 
the 5-day DAFNE program.  Further investigation of the glycaemic impact of this novel 
curriculum is warranted. 
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1. Introduction 
Since the Diabetes Control and Complications Trial (DCCT), where insulin management 
was mostly ‘physician led’ with fixed insulin dose prescription, there has been a move 
toward patient-based insulin management using flexible multiple daily injection (MDI) 
therapy.  There has also been greater recognition of the value of a structured curriculum in 
patient self-management education.  Structured flexible MDI education programs have 
demonstrated improvements in HbA1C1-13, reductions in hypoglycaemia4,6,7,9,10,13,14 and 
improvements in quality of life1,5,12,15 and patient reported outcome measures (such as 
treatment satisfaction, diabetes distress and wellbeing).1,4,5,7,13  Structured education 
programs are characterized by: a clear underlying philosophy, a structured written 
curriculum, a quality assurance process in program development and outcome 
assessment, and delivery by trained facilitators.16  This ensures that education is guided 
by an established curriculum and all patients receive the same teaching, regardless of 
participant variables (eg, previous education or diabetes duration) and facilitator variables.   
 
Flexible MDI education programs differ in design and delivery. Most programs focus on: 
carbohydrate counting, flexible insulin dosing according to carbohydrate content of meals, 
corrective insulin to return blood glucose towards target range and management strategies 
based on daily activities that impact blood glucose levels, such as physical activity, alcohol 
consumption and illness.  Programs address day to day dose determination as well as 
ongoing proactive insulin dose optimisation and may include a psychosocial component 3 
and individual goal setting.17  Many programs are based on adult learning principles and 
support skills based teaching including learning from experience and observation. The 
complex nature of such programs results in a lengthy time commitment with some 
programs conducted over 4 - 5 days.1,5,6,10,17  Many programs deliver this education in a 
group format which, in addition to potentially being more resource efficient, has been 
shown to enhance learning opportunities, as group members are able to contribute varied 
individual experiences and strategies in diabetes management.18   
 
Five-day structured education programs for flexible MDI, which include the  Dose 
Adjustment for Normal Eating (DAFNE) program1 and the  Diabetes Teaching and 
Treatment Program (DTTP),8 have consistently demonstrated beneficial clinical outcomes 
across different countries,7,8,10,13 however  there are barriers to access and delivery of a 5-
day program, which include the impact on work/home life, loss of income and increased 
demand for hospital resources. Short duration flexible MDI education programs include a 
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program reported by Oswald and colleagues, where improvements in glycaemic control 
were seen following participation in a program consisting of group and 1:1 consultations, 
with a mean of 90 minutes of professional contact per patient. 19  Bendik and colleagues 
report reduced frequency of severe hypoglycaemia, improved quality of life and increased 
autonomy in a program delivered in weekly 90 minute sessions over seven weeks.20  
 
Successful flexible MDI self-management requires the patient to: 1) understand day to day 
insulin dose adjustment according to a variety of factors, such as carbohydrate intake, 
blood glucose (BG), physical activity and illness and 2) identify the requirement for 
proactive optimisation of basal insulin doses and bolus insulin algorithms. The curriculum 
topics that address these skills are carbohydrate counting, insulin dose algorithms and 
pattern based evaluation, which have been identified by Grant and colleagues 21 as ‘core’ 
curriculum items for structured flexible MDI self-management education. Participants in the 
5-day program manage the daily dose calculation with little difficulty, but struggle to 
perform proactive insulin optimisation despite practising this on a daily basis in the 5-day 
program. 18 Many 5-day program participants stated a preference to rely on trained health 
professionals to manage this flexible MDI task.22  Offering proactive insulin optimisation 
education and support post course may enable the day to day insulin determinations to be 
taught in a short course format, with proactive insulin optimisation tailored to individual 
requirements post course.   
 
 
We developed the curriculum with the aim of combining the following attributes of flexible 
insulin self-management education  in a novel program, which to the author’s knowledge 
currently doesn’t exist: short course format focusing primarily on skills of carb counting and 
flexible insulin algorithms, use of established insulin algorithms (from DAFNE), use of a 
structured curriculum and with proactive insulin support offered  by experienced facilitators 
on a 1:1 basis, post course. Compared to the 5-day program, the shortened program is 
less time consuming (40 vs 10 hours) and includes only the ‘basic’ components involved in 
daily determination of insulin doses in the setting of flexible MDI therapy.  It doesn’t include 
a number of (5-day program) curriculum components aimed at improving overall 
knowledge (such as diabetes physiology,  exercise physiology, ketone development, 
pregnancy diabetes and travelling with diabetes) and motivation (goal setting).  The risk 
shortening this education is that participants may struggle to learn often complex 
calculations over this time frame and that it  may lead to distress or dissatisfaction. 
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We sought to pilot the program in adults with T1DM and evaluate: 
1) the impact on treatment satisfaction, diabetes distress and wellbeing  
2) the frequency that participants contacted facilitators for assistance with ‘proactive insulin 
optimisation’ support 
3) participant feedback on the curriculum items that were deemed useful 
 
2.  Methods: 
Two specialised DAFNE facilitators (diabetes specialist nurse and diabetes specialist 
dietitian) with experience in DAFNE dosing strategies and adult learning principals 
developed the curriculum to be delivered in two, 5 hour sessions, 1 week apart.  The 
curriculum topics were: carbohydrate counting, BG targets, hypoglycaemia management 
and basal insulin titration strategies (session 1), and bolus insulin dosing algorithms, snack 
dosing, adjustment for exercise, alcohol and sick days and brief introduction to proactive 
insulin optimisation (session 2).  Patients were encouraged to email between session 1 
and 2 for carbohydrate counting support.  Proactive insulin optimisation was briefly 
addressed in session 2 to ensure that participants understood that this was also an 
important part of insulin self-management and would be conducted post course. Post 
course proactive insulin optimisation support was offered in the form of email/phone 
contact, which was encouraged on a weekly basis for 4 weeks after session 2.  A 
structured curriculum was used and participants were provided with learning materials 
(worksheets, carbohydrate counting resources, BG diary, insulin adjustment rules and BG 
targets).  End of study data collection was conducted three months post course.  At this 
time, participants were asked to identify topics they found useful and not useful in a 
shortened curriculum.  Figure 1 outlines the schedule of course delivery, follow up and 
data collection. 
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Adults with T1DM were recruited from this study centre and referrals from local 
endocrinologists. Participants who met the study criteria were sequentially recruited into 
one of four group programs, with up to 8 participants per group.   This ‘patient only’ 
program did not include partners or other family members.   Inclusion criteria for the 
program and study were consistent with the 5-day DAFNE program7 with the following 
exceptions:  HbA1C  7 – 10% (53 – 86 mmol/mol), using rapid acting analogue insulin for 
meals and long acting analogue insulin once or twice/day and agree to test blood glucose 
4 - 6 times/day. Exclusion criteria were:  illness preventing group participation, 
inaccessibility to email or fax, pregnancy or breast feeding and previous attendance at 5-
day DAFNE course. 
 
At baseline, the following data were collected:  age, gender, duration of diabetes and 
history of diabetes complications, and at baseline and study end data collected were 
HbA1C, body mass index, number of severe hypoglycaemic episodes in previous three 
months, number of BG tests performed (over the previous two weeks), number of BG tests 
recorded (over the previous two weeks), Problem Area in Diabetes (PAID questionnaire, 
available from garry@silverfernhealthcare.com), 23,24 Wellbeing questionnaire (W-BQ12, 
available from www.healthpsychologyresearch.com)25,26 and Diabetes Treatment 
Satisfaction Questionnaire (DTSQs, available from 
www.healthpsychologyresearch.com).25,27  DTSQs total score comprises the composite 
score from six items and  total score ranges from 0 to a maximum score of 36, with higher 
scores indicating greater treatment satisfaction.  The W-BQ12 instrument is a measure of 
depressed mood and anxiety (negative well-being subscale), energy and positive well-
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being, however none of the sub-scales are diabetes-specific.  Each of the three subscales 
has four items scored 0 to 3 and a total scoring range of 1 – 12, which contribute to the 
total score (range 0 – 36) with higher scores indicating better well-being.  The PAID 
questionnaire comprises 20 questions that address a range of emotions frequently 
expressed in diabetes and the total score (range 0 – 100) is a measure of diabetes related 
distress, with higher scores indicating greater distress.   
 
Baseline data and change variables were tested for normality using the Shapiro-Wilk test.  
Variables were compared at baseline and post course using the paired t-test for normally 
distributed change variables and the Wilcoxon matched pairs test for the remainder.  For 
categorical data, Fisher’s exact test was used.   Statistical calculations were performed 
using STATISTICA (data analysis software system), version 12.0 (StatSoft, Inc.).   
 
All participants gave their written consent.  The study was approved by the Mater Health 
Services Human Research Ethics Committee. 
 
3. Results 
Twenty one participants were recruited to 4 groups, with 6 participants per group for 2 
groups, 5 in one group and 4 in one group.  Sixteen of the twenty one participants (76%) 
returned for three month follow up.  There was loss to follow up in 3 groups, 1 participant 
in two groups and 3 participants in one group.  Baseline characteristics of participants who 
failed to return for follow-up were similar to those who attended follow up, with the 
exception of the W-BQ12 energy subscale.  Participants who failed to return had a lower 
baseline mean [SD] W-BQ12 energy score (4.2 [1.9]), indicating less energy, compared to 
those who attended follow up (6.8 [2.3], p = 0.039).  
 
Table 1 summarises the short-course outcome data .  The novel program demonstrated 
significant improvements in all psychosocial scores: mean (SD) W-BQ12 from 25 (5) to 28 
(7), mean (SD) DTSQ from 25 (4) to 31(5) and median (IQR) PAID 19 (14-36) to 8 (5-14). 
No statistically significant change was seen post course for HbA1C, either on a whole 
cohort basis or when participants with baseline HbA1C < 7.5% (7/21 participants) were 
excluded from the analysis.  Weight and body mass index were also unchanged.  
Participants failed to conduct SMBG as recommended (4/day, or 56 performed over 2 
weeks) at baseline and post course.  There was no change in the frequency of SMBG or 
SMBG recording or in BMI.  Severe hypoglycaemia was reported by 3 (14%) participants 
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at baseline three months prior to baseline assessment, compared nil post course (data not 
shown). Post course, two participants sent 3 – 4 emails over the 4 weeks post course, two 
participants sent two emails and six participants sent one email.  Seven participants made 
no contact with the facilitator for assistance for post course proactive insulin optimisation.   
 
Table 1: Short course outcomes  
 
Pre  
course 
Post  
course 
p 
HbA1C - % 
              - mmol/mol 
8.0 (0.7) 
64 (8) 
8.0 (0.9) 
64 (10) 
0.969 
0.943 
Weight (kg) 74.6 (70.2 – 82.5) 74.1 (69.1 – 81.9) 0.127 
Body Mass Index (kg/m2) 26.9 (2.9) 26.5 (3.1) 0.202 
No. of BG tests performed 
over 2 weeks 
49.5 (27.1) 51.9 (20.9) 0.783 
No. of BG tests recorded  
over 2 weeks 
0 (0 – 52) 56 (0 – 56) 0.208 
Rapid insulin TDD (U/d) 29.1 (11.7) 24.5 (8.3) 0.132 
Basal insulin TDD (U/d)  28.4 (8.9) 30.3 (9.9) 0.184 
BMI (kg/m2) 26.9 (2.9) 26.5 (3.1) 0.202 
W-BQ12 total score 25 (5) 28 (7) 0.038 
DTSQ overall score 25 (4) 31 (5) <0.001 
PAID overall score 19 (14 - 36) 8 (5 - 14) 0.005 
N = 16. Normally distributed variables described as mean (SD), otherwise as median (IQR). Normally 
distributed baseline variables compared using independent t test, otherwise Mann-Whitney U Test was 
used.  BMI = Body mass index (kg/m2). HbA1C = glycosylated haemoglobin.  TDD = Total daily dose (U/d). 
DTSQ = Diabetes Treatment Satisfaction Questionnaire.  PAID = Problem Areas in Diabetes. W-BQ12 = 12 
item Wellbeing Questionnaire.   
Of the sixteen participants who returned for the three month follow up assessment, fifteen 
were using carbohydrate counting and ratio dosing with insulin algorithms, compared to 
62 
 
none at baseline.  Participants identified the following curriculum topics as most useful: 
carbohydrate counting, using insulin:carbohydrate ratios and learning the process of 
insulin adjustment.  Two participants nominated “learn how to evaluate own insulin doses” 
as useful. 
 
4.  Discussion and conclusion 
4.1 Discussion 
Treatment satisfaction, wellbeing and diabetes distress improves in adults with T1DM 
following participation in a novel ‘short course’ structured flexible MDI education program.   
 
This cohort were similar to the 5-day DAFNE participants in terms of mean SD: HbA1C 
(8.0 1%; 65 11 mmol/mol), diabetes duration (18 11 years), BMI (27 3 kg/m2) and 
frequency of severe hypoglycaemia (29%),7 however they were slightly younger (34.8 
10.7 vs 43.3 14.3 years), and fewer had retinopathy (14 vs 29%) and neuropathy (0 vs 
10%).   
The first Australian audit of the 5-day DAFNE program demonstrated a ‘clinically 
relevant’23 median (IQR) drop in PAID from 25 (15-45) to 16 (10-30) (p< 0.0001)7, which is 
consistent with the mean (SD) drop for the UK audit of 25 (17) to 17 (14) (p<0.001)4.  A 
more recent Australian audit of the 5-day program12 also demonstrated a 10-point drop in 
the PAID score post course.  The 10-point reduction in PAID in the current study suggests 
the short course has an equivalent positive impact on diabetes distress as the 5-day 
program despite lower PAID scores for this cohort at baseline.   
The increase in treatment satisfaction in this cohort is also clinically relevant,28 although 
the magnitude of improvement was slightly less than that seen in the 5-day program,1 
where mean (SD) DTSQ increased from 23 (6) to 32 (4) at 6 months, the post course 
scores were similar.  The higher treatment satisfaction at baseline for this cohort compared 
to the comparison 5-day course, may limit the ability to detect an improvement due to the 
‘ceiling effect’ of this tool29, where ‘close to maximum’ scores at baseline limit the ability to 
see a change or improvement post course.  We chose the DTSCs (status version) which is 
known to be limited by the ceiling effect, to enable comparison to the 5-day DAFNE 
program1.   
The improvement in total wellbeing score of 4 points was similar to that seen in the 5-day 
program,1 where mean (SD) total wellbeing score increased from 21 (6) to 24 (6), six 
months post course.  The lower mean ‘energy’ well being scores in those who failed to 
return for follow up may have limited the improvement seen post course as the greatest 
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gains in quality of life measures are seen with ‘poorer’ measures of quality of life at 
baseline30.  
 
As with the 5-day program, participants in this study were not confident with the process of 
proactive dose optimisation and there was a heavy reliance on the facilitators to direct 
proactive dose decisions.  The limited use of the BG diary (an essential tool in proactive 
insulin optimisation) and the low numbers of participants (n =2) suggesting inclusion of the 
topic, “learn how to evaluate your own insulin doses” in the short-course format, supports 
the notion that participants in this cohort were also reluctant to take on the role of proactive 
insulin optimisation.  The use of email/phone proactive insulin optimisation support in less 
than 50% of participants, suggests either an unwillingness to take on this activity, or that 
the mode of delivery of this support was not suitable, or both.   Most participants (15/16 
94%) were carbohydrate counting and using insulin algorithms by the end of the course. 
 
The short course program failed to influence SMBG frequency and many participants 
failed to conduct SMBG as recommended.  Despite the majority of participants making 
changes to their daily diabetes management (carbohydrate counting and dosing with 
insulin algorithms) change in management did not translate to increasing SMBG 
frequency.  Such a change may represent a greater degree of behaviour modification than 
changing how the insulin is calculated at each meal.  This highlights the  limitation of this 
short course curriculum, which does not address behaviour modification.  In addition, the 
duration of the group interaction may not provide adequate opportunities for participants to 
observe the value of regular SMBG.  More selective inclusion criteria that require 
participants to be demonstrating appropriate SMBG frequency prior to course enrolment 
may be required for those participating in the short course program. 
 
The failure to see an improvement in HbA1c with the short course program may be due to 
limited power to detect a change in HbA1c associated with study size.  Given that the 
majority of participants were conducting intensive management at the end of the course, 
we would hope to see this translate to improvements in glycaemic control, however a more 
rigorous evaluation of glycaemic outcome is warranted. 
 
Limitations 
Compared to 5-day DAFNE participants, this cohort was slightly younger with fewer 
diabetes complications. However, given the similar baseline characteristics and the 
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enrolment of only adults, we do not expect this difference to contribute any bias in our 
study.  The predominance of female participants is consistent with general experience at 
this site for the 5-day DAFNE course and the clinical implications of this bias are expected 
to be minimal.   
 
The comparison of psychosocial data in this cohort (after  briefer 3 month follow up) with 
the 5-day DAFNE program (after 6 and 12 months) may introduce some bias. However 
given that the magnitude in change in PAID, W-BQ12 and DTSQ scores was equivalent to 
that seen at 6 and 12 months with the 5-day program, and the relative stability in these 
quality of life from 6 to 12 months in the 5-day program12 we consider it most likely that 
these changes are seen relatively promptly post course and sustained up to 6 and 12 
months, enabling comparison with these longer term studies. 
 
4.2  Conclusion 
Short-course flexible MDI self-management education is well received by adults with 
T1DM and may be an alternative or adjunctive option for those who are unable to access a 
5-day program. The poor utilisation of post course proactive insulin optimisation support 
reflects the previously observed reluctance to take on this aspect of flexible MDI therapy 
and alternative approaches to supporting proactive insulin optimisation both in the 5-day 
as well as short course format are required.  Evaluation of longer term impact on 
psychosocial as well as glycaemic outcome for this novel program are also warranted.  
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Discussion and implications of findings Chapter 4 
 
This study describes the development of novel short course structured curriculum using 
similar dose algorithms as the DAFNE 5-day curriculum and the impact on patient reported 
outcome measures.   This program was developed by DAFNE facilitators, using DAFNE 
insulin dose algorithms as these were consistent with common practice at the time, 
however the short course program is not part of the OzDAFNE collaborative. 
 
Given the short duration of the program and ‘skills ‘based’ focus on carbohydrate counting 
and insulin dose algorithms, it was acknowledged that the program would not be able to 
address behaviour change and thus aimed to recruit individuals who were already 
conducting some specific important management behaviours of multiple injection therapy. 
As such, the additional inclusion criteria which were added to the standard DAFNE criteria 
were: baseline HbA1c 7 – 10%, already using basal bolus insulin therapy and self-
monitoring of blood glucose 4 – 6 times/day.  The standard DAFNE criteria were also 
used, which were: T1DM, no longer in honeymoon, > 18 years of age, able to read and 
write English, absence of psychiatric illness, not pregnant and able to interact in a group 
setting. 
 
We found adults with T1DM were able to learn how to manage the daily dose calculations 
for flexible MDI following short course participation.  Significant improvements in diabetes 
distress, treatment satisfaction and wellbeing were observed.  The magnitude of 
improvement in these measures appears to be consistent with that seen in the 5-day 
program.  This study confirms that a shortened structured flexible MDI education program 
based on carbohydrate counting and insulin dose algorithms from the 5-day program is 
well accepted in adults with T1DM and improves psychological parameters to the same 
degree as the 5-day program.   
 
For a short-course program to be effective, we believe that it is important to select 
appropriate patients who are already practicing some basic elements of multiple injection 
therapy, as the short course curriculum is likely to be ineffective in changing multiple 
behaviours.  As such, we feel that the full 5-day program will continue to be suitable for 
many patients, but the option for a short-course program is also important, for those who 
may benefit from abbreviated education in the specific skills in use of insulin algorithms.  
Having a short-course option for education will enable health care professionals to deliver 
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targeted education to specific patients over two ½ day sessions (potentially requiring 
health professional input of 2 full days when emails are taken into account) in the place of 
5-full days, which represents a time and cost effective approach. 
Further evaluation of the impact of this short-course format on glycaemic outcomes and 
with a larger cohort is warranted. 
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Chapter 5:  Conclusion 
 
This thesis explores both the dietary behaviours and the patient experience with structured 
flexible MDI education using the OzDAFNE program, and presents novel and original data 
regarding dietary intake and alternative approaches to supporting self-management of 
flexible MDI outside of a 5-day program.  The work has addressed the research questions 
and aims outlined in chapter 1.  In this final chapter, I summarise the main contributions 
that this thesis has made to the field of T1DM intensive management education and 
include suggestions for future research directions. 
 
Main contributions and future research 
The first manuscript addressed the quantitative assessment of the impact of intensive 
flexible MDI therapy education with an active promotion of dietary freedom on energy and 
nutrient intake. This is the first quantitative study of the dietary impact of this educational 
program and supports existing qualitative data, demonstrating that despite an active 
promotion of increased dietary freedom, rather than eat more simple sugar and saturated 
fat containing foods, adults with T1DM took the opportunity to eat less and were able to 
self-manage insulin doses to minimise the risk of hypoglycaemia.  This has implications for 
weight management in insulin users, who are potentially at increased risk of 
hypoglycaemia when choosing to eat less without flexible insulin strategies.   This study 
also confirms few adults with T1DM achieve nutritional recommendations, consistent with 
national and international trends. 
 
The questions that are raised by this study include: 
• Would the active inclusion of advice directed at achievement of nutritional guidelines, 
alongside flexible MDI education improve achievement of nutritional 
recommendations? 
• Is this education superior to standard management for the management of weight in 
overweight or obese individuals with T1DM or those with T2DM using insulin? 
 
Patient-based flexible MDI therapy requires patients to manage often complex 
mathematical calculations on a daily basis, with increased risk of adverse outcome with 
errors in calculation.  In addition, patient-centred management requires effective 
communication between patients and health professionals to enable timely and relevant 
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support to the patient. The second manuscript investigated the user perspectives of a 
novel iphone application designed to support patient-based intensive flexible MDI 
management.  Users found the dose calculator app to be a beneficial adjunct to patient-
based flexible MDI management and reported increased satisfaction and control with this 
device compared to other dose calculators.  Users desired functionality that enabled a 
reduction in the burden of day to day management, such as connectivity with BG meters 
and food databases, shortcut data entry buttons and customisable user interfaces.  Food 
database connectivity potentially creates the link between dietary intake recording and 
dietary assessment creating the potential for the app to interact with the user to feedback 
diet advice to improve diet quality.  This qualitative study has resulted in further 
modification in the Rapidcalc app and plans are currently underway to conduct a clinical 
trial of the app, to evaluate glycaemic outcomes in a larger cohort who have not been 
previously trained in the DAFNE program. 
 
The questions that are raised from this study include: 
• Will users continue to use this app after it is no longer novel and what is the longer 
term impact on glycaemic control? 
• Is there a role for this app in those with low health literacy, who are more at risk of 
making  dose calculation errors? 
• What is the impact on diabetes outcomes, include user satisfaction, with further 
development of the app, incorporating features suggested by users? 
• Is there potential to improve dietary intake with this app with the incorporation of 
automatic response messages based on patient-entered diet history and food data 
base data? 
 
The third manuscript described the development and delivery of a novel short-course 
flexible MDI self-management education program that focuses solely on carbohydrate 
counting and algorithms for insulin dose determination, with proactive insulin optimisation 
offered post course.  Short course flexible MDI therapy enables greater numbers of 
patients and health care centres to access high quality structured education in flexible 
MDI.  Well established insulin dose algorithms from the 5-day OzDAFNE program, 
together with carbohydrate counting formed the core elements of the short program.  We 
were able to confirm that short-course education in flexible MDI is able to reproduce 
improvements to psychosocial outcomes equivalent to a 5-day program.  We also found 
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that that short-course education failed to modify the frequency of blood glucose monitoring 
and the implications for glycaemic outcome are yet to be determined. 
 
The questions that are raised from this study include: 
• What is the impact on glycaemic control? 
• Are there other modes of support to teach proactive insulin optimisation? 
• Are there some individuals who will ‘never’ self-manage proactive insulin optimisation 
and is there a role for an alternative ‘physician-led’ approach in some patients? 
• How do we identify patients willing to self-manage proactive insulin optimisation,  to 
enable more tailored education? 
• How does this short-course program fit into the DAFNE landscape?  Is there scope 
for short-course education first, to enable immediate access to flexible MDI 
education in daily dose determination, then patients move on to DAFNE education? 
• What is the impact of improved access to patient-centred flexible MDI education 
within the health care setting in terms of costs and access to services? 
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